Spyre Therapeutics (SYRE) EBITDA Margin Growth (1y) (2016 - 2023)
Spyre Therapeutics (SYRE) EBITDA Margin Growth (1y) (2016 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Spyre Therapeutics | 257.83 Mn | 257.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -1.96 Mn |
| Mar 31, 2023 | -770,349.00 |
| Dec 31, 2022 | -1.08 Mn |
| Sep 30, 2022 | -1.06 Mn |
| Jun 30, 2022 | -353,872.00 |
| Jun 30, 2018 | 4,772.00 |
| Mar 31, 2018 | 9,868.00 |
| Dec 31, 2017 | -236.00 |
| Sep 30, 2017 | -8,587.00 |
| Jun 30, 2017 | -5,414.00 |
| Mar 31, 2017 | -11,304.00 |
| Dec 31, 2016 | -19,233.00 |
| Sep 30, 2016 | -22,994.00 |
| Jun 30, 2016 | -35,843.00 |